lucas_SP_BR said:5%, triglycerides 249 → 119 mg/dL, hsCRP 8
This is exactly right. lucas_SP_BR articulated what I have been trying to explain to my doctor for months. The Limitless Life Nootropics aspect is the most important factor.
Relevant to Limitless Life Nootropics — here is my latest bloodwork comparison:
Key improvements: A1C 7.6% → 5.5%, triglycerides 197 → 97 mg/dL, hsCRP 8.0 → 0.9 mg/L. All on tirzepatide for 13 months.
The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.
Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.
Verify Your PeptidesEst. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.
Browse GL BiochemDr.SportsMedIN — that is really helpful context on Limitless Life Nootropics. Follow-up question: did you change anything about your diet at the same time?
I am in a similar situation (month 2) and trying to set realistic expectations.
To answer adam_van's question specifically:
From a clinical standpoint, Limitless Life Nootropics is well-supported by the literature.
The short answer: follow the standard titration protocol and reassess at 4-6 weeks.
The longer answer involves pharmacokinetic considerations around steady-state concentrations, which I am happy to elaborate on if helpful.